推广 热搜: 股市  有限公司  企业融资  009  家电  创业  公司  电子商务  服装  服务公司 

Galderma Shareholders Approve All Annual General Meeting Proposals

   2026-04-30 CN-INFO10780
核心提示: ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, announced that shareholders approved all proposals put forward by the Board of Directors at its Annual General Meeting (AGM), he...

ZUG, Switzerland--(BUSINESS WIRE)--Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, announced that shareholders approved all proposals put forward by the Board of Directors at its Annual General Meeting (AGM), held earlier today via live webcast. This includes the payment of a gross dividend of 0.35 CHF per dividend-bearing share1, to be distributed out of reserves from capital contributions.

Shareholders approved the election of Harry Kirsch as independent member of the Board of Directors, as well as the election of Samuel du Retail and Delphine Viguier-Hovasse, representatives of L’Oréal, as non-independent members of the Board. In addition, Thomas Ebeling (Chair), Daniel Browne, Maria Teresa Hilado, Karen Lee Ling, Roberto Marques, Sherilyn McCoy and Dr. Flemming Ørnskov were re-elected to the Board.

The AGM also approved the company’s 2025 Annual Financial Statements, Non-Financial Report and Compensation Report.

Detailed voting results and the official minutes will be published on Galderma's Investor Relations website (https://investors.galderma.com) within the next two weeks.

About Galderma

Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.

1 In accordance with applicable tax regulations and in application of Art. 5 para. 1ter of the Swiss Act on Withholding Tax, 100% of the dividend paid out of reserves from capital contributions will be free from Swiss withholding tax.

 

Contacts

For further information:

Media
Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50

Richard Harbinson
Corporate Communications Director
richard.harbinson@galderma.com
+41 76 210 60 62

Investors
Emil Ivanov
Head of Strategy, Investor Relations and ESG
emil.ivanov@galderma.com
+41 21 642 78 12

Jessica Cohen
Investor Relations and Strategy Director
jessica.cohen@galderma.com
+41 21 642 76 43

 
 
反对 0举报 0 收藏 0 打赏 0评论 0
 
更多>同类资讯
推荐图文
推荐资讯
点击排行
网站首页  |  关于我们  |  服务条款  |  广告合作  |  付款方式  |  使用协议  |  联系我们  |  网站地图  |  排名推广  |  广告服务  |  网站留言  |  RSS订阅  |  违规举报